Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science
Xiangyang, 441138, China
NCT Number: NCT06998511
The Iinterdisciplinary collaborative care model combined with family empowerment (ICCM-FE) intervention based on the COM-B model can effectively improve blood pressure and glucose control in patients with comorbid hypertension and diabetes, enhance their quality of life and psychosocial adaptation, and significantly increase patient satisfaction with nursing care. This intervention has important clinical application value.
Looking for future studies?
Notify Me36 year–58 year
All sexes
Interventional
Not applicable
Xiangyang, 441138, China
To evaluate the efficacy of an interdisciplinary collaborative care model combined with family empowerment (ICCM-FE) based on the COM-B model in managing comorbid hypertension and diabetes, focusing on its impact on blood pressure, glucose control, and psychosocial adaptation. This prospective randomized controlled trial (RCT) enrolled 187 patients with comorbid hypertension and diabetes from January 2023 to March 2024. Patients were randomly assigned to a control group (n = 93) receiving routine care and an observation group (n = 94) receiving ICCM-FE intervention. Follow-up was conducted over 6 months, assessing blood pressure (SBP and DBP), glucose levels (FPG and HbA1c), quality of life (SF-36 scale), psychosocial adaptation (PAIS-SR scale), and nursing satisfaction (NSNS scale) pre- and post-intervention.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The observation group received interdisciplinary collaborative care and family empowerment (ICCM-FE) intervention based on the COM-B model on the basis of routine care.
The control group received routine nursing intervention, including basic drug treatment, diet and exercise guidance, psychological counseling, etc.
Time frame: Baseline and 6 months.
Change in systolic blood pressure (SBP) and diastolic blood pressure (DBP) from baseline to 6 months post-intervention.
Time frame: Baseline and 6 months
Change in SF-36 scores across eight domains (physical function, mental health, role limitations, etc.) from baseline to 6 months post-intervention.
Time frame: Baseline and 6 months.
Change in psychosocial adjustment scores (healthcare orientation, occupational/family environment, psychological stress, etc.) from baseline to 6 months post-intervention.
Time frame: Baseline and 6 months.
Change in General Self-Efficacy Scale (GSES) scores from baseline to 6 months post-intervention.
Time frame: 6 months.
Patient satisfaction with nursing care measured using the Newcastle Satisfaction with Nursing Services Scale (NSNS) at 6 months post-intervention.
Time frame: Monthly for 6 months.
Compliance rates with the interdisciplinary collaborative care model (ICCM-FE) assessed via follow-up attendance and task completion logs.
Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science
Other Gov
Interdisciplinary Collaborative Care Model Combined With Family Empowerment in Patients With Comorbid Hypertension and Diabetes
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00837122
Cardiovascular Diseases, Diabetes
Accra, Ghana
View Trial DetailsNCT05565716
Cardiovascular Diseases, Chronic Disease
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT07532564
Anemia, Anemia, Hemolytic
Baltimore, Maryland, United States
View Trial DetailsNCT04286555
Cardiovascular Diseases, Diabetes
Baltimore, Maryland, United States
View Trial Details